Anti-inflammatory properties of piperlactam S: Modulation of complement 5a-induced chemotaxis and inflammatory cytokines production in macrophages

Planta Medica

Volumn 69, Issue 1, 2003, Pages 9-14

  Chiou, Wen Fei ^a   Peng, Chuen Huei ^b   Chen, Chieh Fu ^a,b   Chou, Cheng Jen ^a  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anti inflammation; Cell spreading; Chemotaxis; Cytokines; Piper kadsura (Choisy) Ohwi; Piperaceae; Piperlactam S

Indexed keywords

ANTIINFLAMMATORY AGENT; COMPLEMENT COMPONENT C5A; CYTOKINE; FIBRINOGEN; INTERLEUKIN 1BETA; PIPER KADSURA EXTRACT; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG ISOLATION; IC 50; MACROPHAGE MIGRATION; MEDICINAL PLANT; MOUSE; NONHUMAN; PHAGOCYTOSIS; PIPER KADSURA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION; CELL LINE; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT C5A; CYTOKINES; INFLAMMATION; LACTAMS; MACROPHAGES; MICE; PIPER;

ANIMALIA; KADSURA; PIPER KADSURA; PIPERACEAE;

EID: 0344643465     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37041     Document Type: Article

References (20)

1. Chung CY, Funamoto S, Firtel RA. Signaling pathways controlling cell polarity and chemotaxis. Trends Biochem Sci 2001; 26: 557-66
2. Paczkowski NJ, Finch AM, Whitmore J, Short AJ, Wong AK, Monk PN, Cain SA, Fairlie DP, Taylor SM. Pharmacological characterization of antagonists of the C5a receptor. Br J Pharmacol 1999; 128: 1461-6
3. Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, Schmal H, Friedl HP, Ward PA. Protective effects of C5a blockade in sepsis. Nat Med 1999; 5: 788-92
4. Heller T, Hennecker M, Baumann U, Gessner JE, Zu Vilsendorf AS, Baensch M, Boulay F, Kola F, Klos A, Bautsch W, Kohl J. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J Immunol 1999; 163: 985-94
5. Han GQ, Dai P, Xu L, Ma J, Ki CL, Zheng QT. PAF inhibitors: Neolignans from Piper kadsura. Planta Med 1990; 56: 583-4
6. Kuo YC, Yang NS, Chou CJ, Lin LC, Tsai WJ. Regulation of cell proliferation, gene expression, production of cytokines, and cell cycle progression in primary human T lymphocytes by piperlactam S isolated from Piper kadsura. Mol Pharmacol 2000; 58: 1057-66
7. Jones GE. Cellular signaling in macrophage migration and chemotaxis. J Leuko Biol 2000; 68: 593-602
8. Fine R, Shaw JO, Rogers WR. Effects of C5a on baboon alveolar macrophage migration. Am Rev Respir Dis 1981; 123: 110-4
9. Shen YC, Chou CJ, Chiou WF, Chen CF. Anti-inflammatory effects of the partially purified extract of Radix Stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fanchinoline on human polymorphonuclear leukocyte functions. Mol Pharmacol 2001; 60: 1083-90
10. Shen YC, Chen CF, Wang SY, Sung YJ. Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 up-regulation and adhesion by tetrandrine. Mol Pharmacol 1999; 55: 186-93
11. Del Rio M, Ruedas G, Medina S, Victor VM, De la Fuente M. Improvement by several antioxidants of macrophage function in vitro. Life Sci 1998; 63: 871-81
12. Warskulate U, Zhang F, Haussinger D. Modulation of phagocytosis by anisoosmolarity and betaine in rat liver macrophages (Kupffer cells) and RAW264.7 mouse macrophages. FEBS Letters 1996; 391: 287-92
13. Sanchez-Madrid F, Del Pozo MA. Leukocyte polarization in cell migration and immune interactions. EMBO J 1999; 18: 501-11
14. Haynes DR, Harkin DG, Bignold LP, Hutchens MJ, Taylor SM, Fairlie DP. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist. Biochem Pharmacol 2000; 60: 729-33
15. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J Biol Chem 1995; 270: 14928-34
16. Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins-1, -6, and -8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes. Arth Rheu 2001; 44: 2176-84
17. Pearce GJ, Chikanza IC. Targeting tumor necrosis factor in the treatment of rheumatoid arthritis. Biodrugs 2001; 15: 139-49
18. Tominaga K, Alstergren P, Kurita H, Matsukawa A, Fukuda J, Kopp S. Interleukin-1beta in antigen-induced arthritis of the rabbit temporomandibular joint. Arch Oral Biol 2001; 46: 539-44
19. Sasaki M, Kashima M, Ito T, Watanabe A, Izumiyama N, Sano M, Kagaya M, Shioya T, Miura M. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha. Med Inflamm 2000; 9: 155-60
20. Ojo-Amaize EA, Kapahi P, Kakkanaiah VN, Takahashi T, Shalom-Barak T, Cottam HB, Adesomoju AA, Nchekwube EJ, Oyemade OA, Karin M, Okogun JI. Hypoestoxide, a novel anti-inflammatory natural diterpene, inhibits the activity of IkappaB kinase. Cellular Immunol 2001; 209: 149- 57